Narendra Bhattarai/LinkedIn
Mar 5, 2026, 14:42
Narendra Bhattarai: Never Label Thrombocytosis as ET Without Excluding CML
Narendra Bhattarai, Attending Hematopathologist at Rochester Regional Health, shared a post on LinkedIn:
“Marked thrombocytosis.
No leukocytosis.
Looks like ET?
Think again.
Unusual CML can present with isolated thrombocytosis, mimicking other myeloproliferative neoplasms.
Don’t miss: Subtle basophilia
- Left shift
- Small hypolobated megakaryocytes
- BCR: ABL1 positivity
Never label thrombocytosis as ET without excluding CML.
One is chronic.
One is targetable.”
Stay updated with Hemostasis Today.
-
Mar 5, 2026, 14:28Deepak Yadav: Is Ablation a Substitute for Anticoagulation in Preventing Recurrent Stroke?
-
Mar 5, 2026, 14:21Leonardo Roever: The Role of Non-Pharmacological Interventions in Post-Stroke Quality of Life
-
Mar 5, 2026, 14:18Heghine Khachatryan: The Overlooked Link Between Homocysteine and Brain Health
-
Mar 5, 2026, 14:14Abdulellah Alkhunfur: Pusher Syndrome or Why Some Stroke Patients Lean Toward the Affected Side
-
Mar 5, 2026, 14:13Annie Bauzon: How the Body Produces Red Blood Cells
-
Mar 5, 2026, 14:07Taiwo Oluwatosin Omolase: How Data-Driven Risk Stratification Can Support Early Stroke Detection and Prevention
-
Mar 5, 2026, 06:18Dino Mehic: Can Global Coagulation Testing Detect Abnormalities in BDUC?
-
Mar 4, 2026, 15:52Manik Madaan: Understanding 4 Hereditary Clotting Disorders
-
Mar 4, 2026, 15:46Samwel Mikaye։ Key Insights on Stroke Types, Diagnosis, and Management